Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prolonged neuromuscular block associated with mivacurium.

British journal of anaesthesia - 1 Feb 1995

Fox M H, Hunt P C

Abstract excerpt

Mivacurium is a relatively new short-acting nondepolarizing neuromuscular blocker. A recommended dose of 0.15-0.2 mg kg-1 provides tracheal intubating conditions within 2.5 min and duration of action of 15-30 min, making it a possible alternative to suxamethonium for short procedures requiring tr...

Topics

Anesthesia Recovery Period
Child
Cholinesterases
Genotype
Humans
Isoquinolines
Male
Mivacurium
Nerve Block
Neuromuscular Junction
Neuromuscular Nondepolarizing Agents
Time Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 7696077
DOI: 10.1093/bja/74.2.237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7696077-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prolonged neuromuscular block associated with mivacurium.PMID 7696077Read ↗

Prolonged mivacurium neuromuscular block in children.Semantic proximity Read ↗

[Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].Semantic proximity Read ↗

Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.Semantic proximity Read ↗

[Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant].Semantic proximity Read ↗

Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.Semantic proximity Read ↗

Clinical importance of plasma cholinesterase for the anaesthetist.Semantic proximity Read ↗

Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients.Semantic proximity Read ↗

Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia.Semantic proximity Read ↗

Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences.Semantic proximity Read ↗

Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.Semantic proximity Read ↗

Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.Semantic proximity Read ↗

Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.